Hellman & Friedman is reportedly looking to sell the drug-eluting stent pioneer for about $9 billion, according to a report ...

Medtronic CEO Geoff Martha shed some light on the company's M&A strategy this week at the J.P. Morgan Healthcare Conference.

There is plenty of opportunity for medtech manufacturers in Asia, but first you need to know how to avoid costly pitfalls.

Elixir Medical's DynamX Bioadaptor restores natural artery function, reducing the risk of future cardiac events.

Launched in 2021, Boston-based Eyebot places its vision testing technology in popular sites like schools, grocery stores, and ...

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

Generative AI in medtech raises questions on safety, validation, and regulatory challenges, explored in MD&M West's "GenMLP" ...

Smith + Nephew is strengthening its shoulder repair portfolio with its latest acquisition target. The London-based company ...

Withings has partnered with Abbott's Lingo CGM to bring glucose monitoring to 15 million users starting Q1 2026 for metabolic ...

While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...

Trends for medical device manufacturers in 2026 include balancing sustainability costs, flexible automation, AI-driven ...

The cotton transistor was considered a step toward creating more complex devices like cotton-based circuits and eventually ...